Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study

Background: Experimental tissue fusion benefits from the selective heating of superparamagnetic iron oxide nanoparticles (SPIONs) under high frequency irradiation. However, the metabolic pathways of SPIONs for tissue fusion remain unknown. Hence, the goal of this in vivo study was to analyze the distribution of SPIONs in different organs by means of magnetic resonance imaging (MRI) and histological analysis after a SPION-containing patch implantation. Methods: SPION-containing patches were implanted in rats. Three animal groups were studied histologically over six months. Degradation assessment of the SPION-albumin patch was performed in vivo using MRI for iron content localization and biodistribution. Results: No SPION degradation or accumulation into the reticuloendothelial system was detected by MRI, MRI relaxometry, or histology, outside the area of the implantation patch. Concentrations from 0.01 μg/mL to 25 μg/mL were found to be hyperintense in T1-like gradient echo sequences. The best differentiation of concentrations was found in T2 relaxometry, susceptibility-sensitive gradient echo sequences, and in high repetition time T2 images. Qualitative and semiquantitative visualization of small concentrations and accumulation of SPIONs by MRI are feasible. In histological liver samples, Kupffer cells were significantly correlated with postimplantation time, but no differences were observed between sham-treated and induction/no induction groups. Transmission electron microscopy showed local uptake of SPIONs in macrophages and cells of the reticuloendothelial system. Apoptosis staining using caspase showed no increased toxicity compared with sham-treated tissue. Implanted SPION patches were relatively inert with slow, progressive local degradation over the six-month period. No distant structural alterations in the studied tissue could be observed. Conclusion: Systemic bioavailability may play a role in specific SPION implant toxicity and therefore the local degradation process is a further aspect to be assessed in future studies.

[1]  C. Bremer,et al.  Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. , 2002, Radiology.

[2]  A. Pérez-Bouza,et al.  Effects of creatine treatment on survival and differentiation of GABA‐ergic neurons in cultured striatal tissue , 2005, Journal of neurochemistry.

[3]  S. Griffey,et al.  Arabinogalactan‐Coated Superparamagnetic Iron Oxide: Effect of Particle Size in Liver MRI , 1995, Journal of computer assisted tomography.

[4]  Craig K. Jones T2 decay curve acquisition and analysis in MRI noise considerations, short T2, and B1 field encoding , 2003 .

[5]  A J Welch,et al.  Optimal parameters for laser tissue soldering. Part I: Tensile strength and scanning electron microscopy analysis , 1999, Lasers in surgery and medicine.

[6]  S. Barry,et al.  Challenges in the development of magnetic particles for therapeutic applications , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[7]  J M Anderson,et al.  Inflammatory response to implants. , 1988, ASAIO transactions.

[8]  A. Curtis,et al.  Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. , 2003, Biomaterials.

[9]  Jürgen Groll,et al.  Phagocytosis independent extracellular nanoparticle clearance by human immune cells. , 2010, Nano letters.

[10]  S. Ammar,et al.  Evaluation of iron oxide nanoparticle biocompatibility , 2011, International journal of nanomedicine.

[11]  Catherine C. Berry,et al.  Progress in functionalization of magnetic nanoparticles for applications in biomedicine , 2009 .

[12]  D. L. Le Couteur,et al.  Basal activity of Kupffer cells increases with old age. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[14]  M. Hashida,et al.  Control of in vivo fate of albumin derivatives utilizing combined chemical modification. , 1994, Journal of drug targeting (Print).

[15]  P. Morais,et al.  Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. , 2001, Biophysical journal.

[16]  P. Babinec,et al.  Selective treatment of neoplastic cells using ferritin-mediated electromagnetic hyperthermia. , 2000, Medical hypotheses.

[17]  R. E. Rosensweig,et al.  Heating magnetic fluid with alternating magnetic field , 2002 .

[18]  E. Monsen Iron nutrition and absorption: dietary factors which impact iron bioavailability. , 1988, Journal of the American Dietetic Association.

[19]  T. Brunner,et al.  Detection of apoptosis in vivo using antibodies against caspase-induced neo-epitopes. , 2008, Methods.

[20]  Atle Bjørnerud,et al.  Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging , 2004, Cell and Tissue Research.

[21]  A. Pérez-Bouza,et al.  Creatine Supplementation Improves Dopaminergic Cell Survival and Protects against MPP+ Toxicity in an Organotypic Tissue Culture System , 2005, Cell transplantation.

[22]  I. Lucet,et al.  Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.

[23]  A. Maitra,et al.  Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. , 2000, International journal of pharmaceutics.

[24]  Karl-Titus Hoffmann,et al.  Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. , 2009, Biomaterials.

[25]  Tobias Schaeffter,et al.  R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing. , 2007, Radiology.

[26]  Ingrid Hilger,et al.  Heating potential of iron oxides for therapeutic purposes in interventional radiology. , 2002, Academic radiology.

[27]  Martin Frenz,et al.  Solder doped polycaprolactone scaffold enables reproducible laser tissue soldering , 2008, Lasers in surgery and medicine.

[28]  M. Reinert,et al.  Electromagnetic Tissue Fusion Using Superparamagnetic Iron Oxide Nanoparticles: First Experience with Rabbit Aorta , 2008 .